Skip to main content


At JDRF, we are dedicated to making a positive impact on the lives of everyone living with type 1 diabetes by actively participating in advocacy work.

Two men dressed in smart suits discussing JDRF's policy and advocacy projects, and their philanthropy programme

Our approach to policy

Our goal is to shape healthcare consultations regarding access to new treatments and technology. You can learn more about our efforts in influencing policies that affect people with type 1 by exploring our comprehensive policy papers.

Collaborating with healthcare providers

A crucial aspect of our work involves actively engaging and responding to consultations from public bodies such as the National Health Service (NHS), the National Institute for Health and Care Excellence (NICE), and the UK and Devolved Governments.

We contribute real-life case studies, gather insights from academic experts and healthcare professionals, ensuring that the unique needs and challenges of people with type 1 diabetes are taken into account when making healthcare decisions and developing guidelines.

We regularly publish our policy positions on key issues related to type 1 diabetes. These positions are based on expert research, input from the type 1 community, and the valuable insights provided by individuals and professionals in the field. By making our positions publicly available, we aim to raise awareness and advocate for necessary changes that will enhance the lives of everyone living with type 1 diabetes.

Collaborating with Government

We actively engage in efforts to influence government policies through briefings and meetings with Parliamentarians. By working closely with policymakers, we strive to ensure that the concerns and voices of the type 1 diabetes community are heard and addressed.

Through strategic advocacy, we aim to drive policy changes that enhance access to innovative treatments, support research funding, and improve overall healthcare for all individuals with type 1 diabetes.

Related news

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Policy and advocacy Treatment research Treatments Type 1 technology
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
A young guy with type 1 diabetes dealing with exam stress and taking an exam
Policy and advocacy
4 October 2023

Letter to Gillian Keegan about the use of mobile phones in schools

We’ve written a letter to Gillian Keegan MP, Secretary of State for Education, asking her to make exemptions to the Government’s policy on banning mobile phones in schools. We thought you might like to read it.

Read more
Illustration of the hybrid closed loop technology system, funded as part of treatment research for type 1 diabetes by JDRF.
Policy and advocacy Type 1 technology
21 August 2023

NICE’s latest consultation on hybrid closed loop

As part of its assessment of hybrid closed loop (HCL), the National Institute for Health and Care Excellence (NICE) has today published an additional consultation on its roll out.

Read more
A woman standing in a park using the Omnipod 5 system for type 1 diabetes
Type 1 technology
21 June 2023

Omnipod 5 becomes the latest hybrid closed loop system available in the UK

Insulet, the company who make Omnipod® products, has announced that their Omnipod® 5 hybrid closed loop (HCL) technology is now available in the UK.

Join our social communities